SparingVision to Participate in Upcoming Investor and Industry Conferences
Paris, September 22, 2022 – SparingVision (“the Company”), today announces investor and industry conferences that its management team will attend in the second half of 2022:
Jefferies Cell & Genetic Medicine Summit, New York City, USA – 28-29 September
- Fireside Chat, Stephane Boissel, President & CEO (September 29, 3:00-3:25 pm EST)
A live webcast and replay of the presentation will be available in the “News & Media” section of SparingVision’s website here: Presentations & Webcasts – Sparing Vision
Chardan’s Annual Genetic Medicines Conference, New York City, USA – 3-4 October
- Company presentation, Stephane Boissel, President & CEO (October 4, 8:00-8:25 am EST)
A live webcast and replay of the presentation will be available in the “News & Media” section of SparingVision’s website here: Presentations & Webcasts – Sparing Vision
Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa, Carlsbad (CA) USA- 11-13 October
- Company presentation, Stephane Boissel, President & CEO (October 12, 2:15 pm-2:30 pm EST)
BMO/Solebury Trout’s Fall Private Connect, New York City, USA – 13 October
- Company presentation, Stephane Boissel, President & CEO (October 13, 12:40 pm EST)
McDermott’s European Health and Life Sciences Symposium 2022, Paris, France 18 October
Jefferies Healthcare Conference, London, UK – 15-17 November
**ENDS**